Cargando…
Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation
Non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, calls for better therapy. Yi-Fei-San-Jie-pill (YFSJ), a well-applicated traditional Chinese medicine formula, was reported to be effective in the treatment of NSCLC. However, its anti-tumor mechanism still needs to be f...
Autores principales: | Yang, Hongxing, Guo, Qiuyan, Wu, Jianbin, Zhong, Lixia, Sun, Lingling, Liu, Wei, Wang, Jigang, Lin, Lizhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130494/ https://www.ncbi.nlm.nih.gov/pubmed/35645820 http://dx.doi.org/10.3389/fphar.2022.851554 |
Ejemplares similares
-
A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification
por: Hu, Leihao, et al.
Publicado: (2023) -
The TCM Prescription Yi-Fei-Jie-Du-Tang Inhibit Invasive Migration and EMT of Lung Cancer Cells by Activating Autophagy
por: Wang, Shanshan, et al.
Publicado: (2022) -
Qu-Du-San-Jie decoction induces growth inhibition and vascular normalization in NF2-associated vestibular schwannoma
por: Lin, Jie, et al.
Publicado: (2022) -
Integrating network pharmacology and experimental verification to decipher the immunomodulatory effect of Bu-Zhong-Yi-Qi-Tang against poly (I:C)-induced pulmonary inflammation
por: Hu, Liufang, et al.
Publicado: (2022) -
Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach
por: Lang, Wanying, et al.
Publicado: (2022)